Rank | Gene Set | Z-score |
---|---|---|
1 | sarcomere organization (GO:0045214) | 9.23173288 |
2 | actin-myosin filament sliding (GO:0033275) | 8.96952292 |
3 | muscle filament sliding (GO:0030049) | 8.96952292 |
4 | regulation of skeletal muscle contraction (GO:0014819) | 7.93887636 |
5 | myofibril assembly (GO:0030239) | 7.68890155 |
6 | cardiac myofibril assembly (GO:0055003) | 7.66273436 |
7 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.36679763 |
8 | actin-mediated cell contraction (GO:0070252) | 7.35442858 |
9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.25994734 |
10 | plasma membrane repair (GO:0001778) | 6.99171562 |
11 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.94595865 |
12 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.53466100 |
13 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.47617855 |
14 | cardiac muscle contraction (GO:0060048) | 6.38903555 |
15 | tricarboxylic acid cycle (GO:0006099) | 6.24741485 |
16 | skeletal muscle contraction (GO:0003009) | 6.03766396 |
17 | striated muscle contraction (GO:0006941) | 6.03138187 |
18 | cardiac muscle cell development (GO:0055013) | 5.85535660 |
19 | regulation of relaxation of muscle (GO:1901077) | 5.85191565 |
20 | actomyosin structure organization (GO:0031032) | 5.84154368 |
21 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.74264489 |
22 | regulation of actin filament-based movement (GO:1903115) | 5.70712110 |
23 | carnitine shuttle (GO:0006853) | 5.66400412 |
24 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.63334395 |
25 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.55655198 |
26 | skeletal muscle fiber development (GO:0048741) | 5.54296512 |
27 | regulation of cell communication by electrical coupling (GO:0010649) | 5.49744315 |
28 | cardiac cell development (GO:0055006) | 5.48538595 |
29 | actin filament-based movement (GO:0030048) | 5.48453468 |
30 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.43767500 |
31 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.22257878 |
32 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.16420351 |
33 | creatine metabolic process (GO:0006600) | 5.06651367 |
34 | myotube cell development (GO:0014904) | 5.04222953 |
35 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.03478115 |
36 | skeletal muscle adaptation (GO:0043501) | 4.95258949 |
37 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.94227470 |
38 | cardiac muscle hypertrophy (GO:0003300) | 4.92295803 |
39 | adult heart development (GO:0007512) | 4.89960305 |
40 | fatty acid transmembrane transport (GO:1902001) | 4.84683018 |
41 | heart process (GO:0003015) | 4.83574705 |
42 | heart contraction (GO:0060047) | 4.83574705 |
43 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.82101640 |
44 | striated muscle hypertrophy (GO:0014897) | 4.77776216 |
45 | regulation of cofactor metabolic process (GO:0051193) | 4.76052778 |
46 | regulation of coenzyme metabolic process (GO:0051196) | 4.76052778 |
47 | regulation of striated muscle contraction (GO:0006942) | 4.73453923 |
48 | muscle tissue morphogenesis (GO:0060415) | 4.65846133 |
49 | regulation of sarcomere organization (GO:0060297) | 4.61789410 |
50 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.60824211 |
51 | heart trabecula formation (GO:0060347) | 4.48345719 |
52 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.48173743 |
53 | glycogen biosynthetic process (GO:0005978) | 4.40333577 |
54 | glucan biosynthetic process (GO:0009250) | 4.40333577 |
55 | response to inactivity (GO:0014854) | 4.39779574 |
56 | muscle contraction (GO:0006936) | 4.34109808 |
57 | skeletal muscle tissue development (GO:0007519) | 4.32987293 |
58 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.32648455 |
59 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.30620886 |
60 | regulation of membrane repolarization (GO:0060306) | 4.24881446 |
61 | muscle hypertrophy (GO:0014896) | 4.20775206 |
62 | carnitine transmembrane transport (GO:1902603) | 4.19232113 |
63 | cellular polysaccharide catabolic process (GO:0044247) | 4.18095935 |
64 | striated muscle adaptation (GO:0014888) | 4.10224548 |
65 | respiratory electron transport chain (GO:0022904) | 4.06627262 |
66 | oxidative phosphorylation (GO:0006119) | 4.03856641 |
67 | NADH metabolic process (GO:0006734) | 4.01716151 |
68 | muscle cell cellular homeostasis (GO:0046716) | 4.00563369 |
69 | muscle system process (GO:0003012) | 3.99096216 |
70 | ATP synthesis coupled proton transport (GO:0015986) | 3.98821878 |
71 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.98821878 |
72 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.96782566 |
73 | electron transport chain (GO:0022900) | 3.94266948 |
74 | regulation of sequestering of triglyceride (GO:0010889) | 3.94089654 |
75 | skeletal muscle tissue regeneration (GO:0043403) | 3.92944150 |
76 | 2-oxoglutarate metabolic process (GO:0006103) | 3.92441106 |
77 | striated muscle cell development (GO:0055002) | 3.91435761 |
78 | response to muscle activity (GO:0014850) | 3.89670178 |
79 | striated muscle atrophy (GO:0014891) | 3.88554861 |
80 | glycogen catabolic process (GO:0005980) | 3.86240883 |
81 | regulation of the force of heart contraction (GO:0002026) | 3.85701557 |
82 | regulation of sulfur metabolic process (GO:0042762) | 3.84770038 |
83 | amino-acid betaine transport (GO:0015838) | 3.81616741 |
84 | carnitine transport (GO:0015879) | 3.81616741 |
85 | polysaccharide catabolic process (GO:0000272) | 3.81528492 |
86 | muscle cell fate commitment (GO:0042693) | 3.75504553 |
87 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.74516918 |
88 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.74516918 |
89 | cardiac muscle adaptation (GO:0014887) | 3.72031817 |
90 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.72031817 |
91 | muscle hypertrophy in response to stress (GO:0003299) | 3.72031817 |
92 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.68748858 |
93 | regulation of ATP catabolic process (GO:1903289) | 3.67951680 |
94 | regulation of ATPase activity (GO:0043462) | 3.67951680 |
95 | cell communication involved in cardiac conduction (GO:0086065) | 3.65535720 |
96 | glucan catabolic process (GO:0009251) | 3.59907011 |
97 | positive regulation of myotube differentiation (GO:0010831) | 3.59503085 |
98 | muscle organ development (GO:0007517) | 3.58159148 |
99 | muscle structure development (GO:0061061) | 3.57963472 |
100 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.57620862 |
101 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.57620862 |
102 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.57328555 |
103 | negative regulation of potassium ion transport (GO:0043267) | 3.56392370 |
104 | muscle fiber development (GO:0048747) | 3.55441329 |
105 | glycogen metabolic process (GO:0005977) | 3.53771275 |
106 | cytidine deamination (GO:0009972) | 3.52508174 |
107 | cytidine metabolic process (GO:0046087) | 3.52508174 |
108 | cytidine catabolic process (GO:0006216) | 3.52508174 |
109 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.52126238 |
110 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.50511758 |
111 | positive regulation of cation channel activity (GO:2001259) | 3.50368900 |
112 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.48806135 |
113 | negative regulation of protein localization to cell surface (GO:2000009) | 3.47798399 |
114 | cardiac muscle cell action potential (GO:0086001) | 3.47720894 |
115 | gluconeogenesis (GO:0006094) | 3.47049998 |
116 | cellular glucan metabolic process (GO:0006073) | 3.46438804 |
117 | glucan metabolic process (GO:0044042) | 3.46438804 |
118 | regulation of cardiac muscle contraction (GO:0055117) | 3.44088435 |
119 | regulation of heart rate (GO:0002027) | 3.43525233 |
120 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.43400102 |
121 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.42983422 |
122 | regulation of muscle system process (GO:0090257) | 3.41735754 |
123 | muscle adaptation (GO:0043500) | 3.41438133 |
124 | muscle cell development (GO:0055001) | 3.41369165 |
125 | regulation of muscle contraction (GO:0006937) | 3.40871795 |
126 | response to activity (GO:0014823) | 3.37658097 |
127 | muscle atrophy (GO:0014889) | 3.35390636 |
128 | regulation of myoblast differentiation (GO:0045661) | 3.34931247 |
129 | fructose metabolic process (GO:0006000) | 3.34874786 |
130 | relaxation of muscle (GO:0090075) | 3.26875079 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.90139531 |
2 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.71859013 |
3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.36819426 |
4 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.04250064 |
5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.01015612 |
6 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.01015612 |
7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.87419738 |
8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.84102083 |
9 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.46559131 |
10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.42718080 |
11 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.29728220 |
12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.99125100 |
13 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.94486422 |
14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.72610285 |
15 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.33001811 |
16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.27968852 |
17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.15842792 |
18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.01073586 |
19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.90656144 |
20 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.87353044 |
21 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.82070950 |
22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.80114554 |
23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.74445838 |
24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.73670306 |
25 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.72471851 |
26 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.70955501 |
27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.66352326 |
28 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.64450367 |
29 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63312296 |
30 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.63216378 |
31 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.63198611 |
32 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.61474982 |
33 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.60274452 |
34 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.49558665 |
35 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.45295010 |
36 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.45280042 |
37 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.43848142 |
38 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.43406147 |
39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35562368 |
40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.31271692 |
41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27580201 |
42 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.25529565 |
43 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.24917184 |
44 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24384537 |
45 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.22275585 |
46 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.21488462 |
47 | ATF3_27146783_Chip-Seq_COLON_Human | 1.20958012 |
48 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20811920 |
49 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.20506137 |
50 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.19663356 |
51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18913024 |
52 | * P68_20966046_ChIP-Seq_HELA_Human | 1.17255157 |
53 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.15173924 |
54 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.14963308 |
55 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.14514037 |
56 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.12696330 |
57 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11848139 |
58 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.11583233 |
59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11253370 |
60 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07665717 |
61 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.06804095 |
62 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06454698 |
63 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.04907940 |
64 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.04599629 |
65 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.04464478 |
66 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04118441 |
67 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.02062574 |
68 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.01167801 |
69 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.00914687 |
70 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 1.00559772 |
71 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.00204939 |
72 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.99749189 |
73 | VDR_22108803_ChIP-Seq_LS180_Human | 0.99714811 |
74 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99628394 |
75 | SA1_27219007_Chip-Seq_Bcells_Human | 0.99133837 |
76 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98825352 |
77 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.98823841 |
78 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.96992845 |
79 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95944530 |
80 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95129487 |
81 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.94989160 |
82 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.94501160 |
83 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.94304695 |
84 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.93570032 |
85 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92803081 |
86 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.91821966 |
87 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.90741616 |
88 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.90453890 |
89 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.90385951 |
90 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.89794418 |
91 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.89787120 |
92 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.87749330 |
93 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.87735267 |
94 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.87626175 |
95 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.87619150 |
96 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.86838245 |
97 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.86796312 |
98 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.86511277 |
99 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86362419 |
100 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.85217437 |
101 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83250224 |
102 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82901273 |
103 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.82876300 |
104 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.81505936 |
105 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80718288 |
106 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.80038519 |
107 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.79743509 |
108 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79522249 |
109 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.79184170 |
110 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.79173081 |
111 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.79059080 |
112 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.78174740 |
113 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.78111335 |
114 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.77691449 |
115 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.77499517 |
116 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.76621853 |
117 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.75820234 |
118 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75753190 |
119 | GATA1_22025678_ChIP-Seq_K562_Human | 0.75498655 |
120 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.75259893 |
121 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74984243 |
122 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.73973682 |
123 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.73111515 |
124 | GATA2_19941826_ChIP-Seq_K562_Human | 0.72230246 |
125 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.72048026 |
126 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71644554 |
127 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.71207989 |
128 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.71041927 |
129 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.70967234 |
130 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.70828420 |
131 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.70414639 |
132 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.70364655 |
133 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.70171642 |
134 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.69926745 |
135 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.69877781 |
136 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.68688883 |
137 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.68588082 |
138 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.68491712 |
139 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.68384467 |
140 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.67679428 |
141 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.67679428 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003646_muscle_fatigue | 6.52664985 |
2 | MP0002837_dystrophic_cardiac_calcinosis | 6.50841613 |
3 | MP0000751_myopathy | 5.66290028 |
4 | MP0000749_muscle_degeneration | 4.86351765 |
5 | MP0004084_abnormal_cardiac_muscle | 4.79874197 |
6 | MP0004036_abnormal_muscle_relaxation | 4.33787925 |
7 | MP0004215_abnormal_myocardial_fiber | 3.99726073 |
8 | MP0004145_abnormal_muscle_electrophysio | 3.87158007 |
9 | * MP0005330_cardiomyopathy | 3.32330320 |
10 | * MP0004087_abnormal_muscle_fiber | 3.30438814 |
11 | MP0002106_abnormal_muscle_physiology | 3.16957232 |
12 | MP0000750_abnormal_muscle_regeneration | 3.16200025 |
13 | MP0005620_abnormal_muscle_contractility | 2.89277152 |
14 | MP0002269_muscular_atrophy | 2.86713493 |
15 | MP0004130_abnormal_muscle_cell | 2.83691640 |
16 | MP0000747_muscle_weakness | 2.83170927 |
17 | MP0000759_abnormal_skeletal_muscle | 2.66320877 |
18 | * MP0002972_abnormal_cardiac_muscle | 2.62756723 |
19 | MP0005369_muscle_phenotype | 2.59809287 |
20 | MP0003137_abnormal_impulse_conducting | 2.41827454 |
21 | MP0008775_abnormal_heart_ventricle | 2.36785426 |
22 | MP0004484_altered_response_of | 2.30089579 |
23 | MP0005385_cardiovascular_system_phenoty | 2.27350807 |
24 | MP0001544_abnormal_cardiovascular_syste | 2.27350807 |
25 | * MP0010630_abnormal_cardiac_muscle | 2.26214029 |
26 | MP0004233_abnormal_muscle_weight | 2.12224612 |
27 | MP0006138_congestive_heart_failure | 1.97937639 |
28 | MP0006036_abnormal_mitochondrial_physio | 1.96936640 |
29 | MP0002332_abnormal_exercise_endurance | 1.80895061 |
30 | MP0003828_pulmonary_edema | 1.73208760 |
31 | MP0004085_abnormal_heartbeat | 1.65455415 |
32 | MP0005666_abnormal_adipose_tissue | 1.57332135 |
33 | * MP0003221_abnormal_cardiomyocyte_apopto | 1.42216030 |
34 | MP0002127_abnormal_cardiovascular_syste | 1.40688648 |
35 | MP0004510_myositis | 1.40458050 |
36 | MP0003950_abnormal_plasma_membrane | 1.39278039 |
37 | MP0004185_abnormal_adipocyte_glucose | 1.33105826 |
38 | MP0002108_abnormal_muscle_morphology | 1.26385475 |
39 | MP0005670_abnormal_white_adipose | 1.24702260 |
40 | MP0004270_analgesia | 1.21188019 |
41 | MP0000733_abnormal_muscle_development | 1.18846098 |
42 | MP0002234_abnormal_pharynx_morphology | 1.14206418 |
43 | MP0006035_abnormal_mitochondrial_morpho | 1.12273287 |
44 | MP0000343_altered_response_to | 1.12006185 |
45 | MP0005375_adipose_tissue_phenotype | 1.08445902 |
46 | MP0005266_abnormal_metabolism | 1.02777920 |
47 | * MP0000266_abnormal_heart_morphology | 1.00788084 |
48 | MP0001661_extended_life_span | 0.98425561 |
49 | MP0003567_abnormal_fetal_cardiomyocyte | 0.98036464 |
50 | MP0003806_abnormal_nucleotide_metabolis | 0.91120480 |
51 | MP0005165_increased_susceptibility_to | 0.86869326 |
52 | MP0002971_abnormal_brown_adipose | 0.82718804 |
53 | MP0003279_aneurysm | 0.74147594 |
54 | MP0003705_abnormal_hypodermis_morpholog | 0.73949977 |
55 | MP0004043_abnormal_pH_regulation | 0.70067910 |
56 | MP0000230_abnormal_systemic_arterial | 0.67683889 |
57 | MP0000013_abnormal_adipose_tissue | 0.67235637 |
58 | MP0010368_abnormal_lymphatic_system | 0.66044459 |
59 | MP0009780_abnormal_chondrocyte_physiolo | 0.65429571 |
60 | MP0000003_abnormal_adipose_tissue | 0.61060953 |
61 | MP0004147_increased_porphyrin_level | 0.61016325 |
62 | * MP0002128_abnormal_blood_circulation | 0.60297395 |
63 | MP0002909_abnormal_adrenal_gland | 0.53992530 |
64 | MP0002078_abnormal_glucose_homeostasis | 0.52008688 |
65 | MP0003566_abnormal_cell_adhesion | 0.51510211 |
66 | MP0005319_abnormal_enzyme/_coenzyme | 0.48961706 |
67 | MP0005623_abnormal_meninges_morphology | 0.48803168 |
68 | MP0008961_abnormal_basal_metabolism | 0.48103756 |
69 | MP0000372_irregular_coat_pigmentation | 0.47384353 |
70 | MP0003879_abnormal_hair_cell | 0.46339767 |
71 | MP0005167_abnormal_blood-brain_barrier | 0.44779201 |
72 | MP0005451_abnormal_body_composition | 0.44567635 |
73 | MP0005275_abnormal_skin_tensile | 0.44239080 |
74 | MP0000767_abnormal_smooth_muscle | 0.43878431 |
75 | MP0002638_abnormal_pupillary_reflex | 0.43240252 |
76 | MP0001879_abnormal_lymphatic_vessel | 0.42237818 |
77 | MP0005187_abnormal_penis_morphology | 0.40754250 |
78 | MP0005334_abnormal_fat_pad | 0.38094304 |
79 | MP0002925_abnormal_cardiovascular_devel | 0.35445198 |
80 | MP0005083_abnormal_biliary_tract | 0.34531134 |
81 | MP0004134_abnormal_chest_morphology | 0.33259060 |
82 | MP0005423_abnormal_somatic_nervous | 0.32638290 |
83 | MP0008438_abnormal_cutaneous_collagen | 0.31996688 |
84 | MP0003656_abnormal_erythrocyte_physiolo | 0.31817782 |
85 | MP0009672_abnormal_birth_weight | 0.31575443 |
86 | MP0005535_abnormal_body_temperature | 0.31047444 |
87 | MP0003948_abnormal_gas_homeostasis | 0.30956189 |
88 | MP0005332_abnormal_amino_acid | 0.29557271 |
89 | MP0004142_abnormal_muscle_tone | 0.29348129 |
90 | MP0002822_catalepsy | 0.28069559 |
91 | MP0003984_embryonic_growth_retardation | 0.27845350 |
92 | MP0009115_abnormal_fat_cell | 0.27574338 |
93 | MP0009840_abnormal_foam_cell | 0.27524261 |
94 | MP0001614_abnormal_blood_vessel | 0.27300606 |
95 | MP0005166_decreased_susceptibility_to | 0.27203626 |
96 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.26592494 |
97 | MP0002088_abnormal_embryonic_growth/wei | 0.26466019 |
98 | MP0001853_heart_inflammation | 0.25784465 |
99 | MP0010030_abnormal_orbit_morphology | 0.25284004 |
100 | MP0001784_abnormal_fluid_regulation | 0.25134331 |
101 | MP0005452_abnormal_adipose_tissue | 0.25130300 |
102 | MP0002118_abnormal_lipid_homeostasis | 0.24102388 |
103 | MP0005376_homeostasis/metabolism_phenot | 0.24033580 |
104 | MP0002114_abnormal_axial_skeleton | 0.23789585 |
105 | MP0000762_abnormal_tongue_morphology | 0.23715222 |
106 | MP0002734_abnormal_mechanical_nocicepti | 0.22781543 |
107 | MP0002896_abnormal_bone_mineralization | 0.22505610 |
108 | MP0003195_calcinosis | 0.22306404 |
109 | MP0001727_abnormal_embryo_implantation | 0.21468867 |
110 | MP0003045_fibrosis | 0.21319844 |
111 | MP0001299_abnormal_eye_distance/ | 0.21261290 |
112 | MP0008569_lethality_at_weaning | 0.20902856 |
113 | MP0004924_abnormal_behavior | 0.19107157 |
114 | MP0005386_behavior/neurological_phenoty | 0.19107157 |
115 | MP0009250_abnormal_appendicular_skeleto | 0.18486522 |
116 | MP0002970_abnormal_white_adipose | 0.18424931 |
117 | MP0008874_decreased_physiological_sensi | 0.18090502 |
118 | * MP0002066_abnormal_motor_capabilities/c | 0.17903609 |
119 | MP0000579_abnormal_nail_morphology | 0.17756606 |
120 | MP0003941_abnormal_skin_development | 0.17041470 |
121 | MP0001943_abnormal_respiration | 0.17000497 |
122 | MP0002877_abnormal_melanocyte_morpholog | 0.16236879 |
123 | MP0000249_abnormal_blood_vessel | 0.15443762 |
124 | MP0000358_abnormal_cell_content/ | 0.14798373 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Exercise-induced myalgia (HP:0003738) | 7.41116642 |
2 | Exercise-induced muscle cramps (HP:0003710) | 7.08300874 |
3 | Calf muscle hypertrophy (HP:0008981) | 6.95156515 |
4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.85960706 |
5 | Sudden death (HP:0001699) | 6.48927773 |
6 | Muscle fiber splitting (HP:0003555) | 6.11940631 |
7 | Ventricular tachycardia (HP:0004756) | 5.67366750 |
8 | Myoglobinuria (HP:0002913) | 5.48750318 |
9 | Hyporeflexia of lower limbs (HP:0002600) | 5.47505179 |
10 | Muscle fiber inclusion bodies (HP:0100299) | 5.47023590 |
11 | Abnormality of the calf musculature (HP:0001430) | 5.35666187 |
12 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.32190899 |
13 | EMG: myopathic abnormalities (HP:0003458) | 4.74557702 |
14 | Difficulty running (HP:0009046) | 4.72626510 |
15 | Subaortic stenosis (HP:0001682) | 4.69196705 |
16 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.69196705 |
17 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.60362852 |
18 | Nemaline bodies (HP:0003798) | 4.60145756 |
19 | Atrial fibrillation (HP:0005110) | 4.59869329 |
20 | Increased connective tissue (HP:0009025) | 4.56983537 |
21 | Type 1 muscle fiber predominance (HP:0003803) | 4.39665915 |
22 | Rhabdomyolysis (HP:0003201) | 4.37039910 |
23 | Lipoatrophy (HP:0100578) | 4.32497737 |
24 | Primary atrial arrhythmia (HP:0001692) | 4.29823732 |
25 | Supraventricular tachycardia (HP:0004755) | 4.16266372 |
26 | Supraventricular arrhythmia (HP:0005115) | 4.06850267 |
27 | Myotonia (HP:0002486) | 3.98810823 |
28 | Right ventricular cardiomyopathy (HP:0011663) | 3.93996817 |
29 | Asymmetric septal hypertrophy (HP:0001670) | 3.92437813 |
30 | Bundle branch block (HP:0011710) | 3.88490813 |
31 | Dilated cardiomyopathy (HP:0001644) | 3.71714075 |
32 | Palpitations (HP:0001962) | 3.61559748 |
33 | Difficulty climbing stairs (HP:0003551) | 3.54509961 |
34 | Muscle stiffness (HP:0003552) | 3.53549279 |
35 | Distal arthrogryposis (HP:0005684) | 3.46003944 |
36 | Syncope (HP:0001279) | 3.36380393 |
37 | Myopathic facies (HP:0002058) | 3.31671158 |
38 | Round ear (HP:0100830) | 3.20673865 |
39 | Prolonged QT interval (HP:0001657) | 3.18895136 |
40 | Heart block (HP:0012722) | 3.17859809 |
41 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.16822938 |
42 | Areflexia of lower limbs (HP:0002522) | 3.13206002 |
43 | Increased variability in muscle fiber diameter (HP:0003557) | 3.12320167 |
44 | Ventricular arrhythmia (HP:0004308) | 3.08016660 |
45 | Distal lower limb muscle weakness (HP:0009053) | 3.06654406 |
46 | Abnormal atrioventricular conduction (HP:0005150) | 3.00974954 |
47 | Neck muscle weakness (HP:0000467) | 2.99494735 |
48 | Atrioventricular block (HP:0001678) | 2.91507476 |
49 | Ulnar deviation of the wrist (HP:0003049) | 2.73716523 |
50 | Rimmed vacuoles (HP:0003805) | 2.73076196 |
51 | Abnormal finger flexion creases (HP:0006143) | 2.70815942 |
52 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.68549888 |
53 | Acute necrotizing encephalopathy (HP:0006965) | 2.66607065 |
54 | Limb-girdle muscle atrophy (HP:0003797) | 2.63179008 |
55 | Ventricular fibrillation (HP:0001663) | 2.59704516 |
56 | Hepatic necrosis (HP:0002605) | 2.58733406 |
57 | Weak cry (HP:0001612) | 2.48752150 |
58 | Fetal akinesia sequence (HP:0001989) | 2.46784998 |
59 | Left ventricular hypertrophy (HP:0001712) | 2.43209465 |
60 | Testicular atrophy (HP:0000029) | 2.41548307 |
61 | EMG: neuropathic changes (HP:0003445) | 2.35249527 |
62 | Ketoacidosis (HP:0001993) | 2.34887292 |
63 | Abnormal EKG (HP:0003115) | 2.33734989 |
64 | Ragged-red muscle fibers (HP:0003200) | 2.32728578 |
65 | Distal lower limb amyotrophy (HP:0008944) | 2.31367430 |
66 | Acute encephalopathy (HP:0006846) | 2.30223782 |
67 | Hepatocellular necrosis (HP:0001404) | 2.29958658 |
68 | Muscular dystrophy (HP:0003560) | 2.27644519 |
69 | Gowers sign (HP:0003391) | 2.26196623 |
70 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.24270787 |
71 | Increased muscle lipid content (HP:0009058) | 2.20802643 |
72 | Hypoplastic ischia (HP:0003175) | 2.20689300 |
73 | Slender build (HP:0001533) | 2.19959546 |
74 | Generalized muscle weakness (HP:0003324) | 2.19096371 |
75 | Progressive macrocephaly (HP:0004481) | 2.18594084 |
76 | Exercise intolerance (HP:0003546) | 2.18499949 |
77 | Calcaneovalgus deformity (HP:0001848) | 2.17811747 |
78 | Facial diplegia (HP:0001349) | 2.16295838 |
79 | Palmoplantar keratoderma (HP:0000982) | 2.15105202 |
80 | Hip contracture (HP:0003273) | 2.15031513 |
81 | Mitochondrial inheritance (HP:0001427) | 2.15028551 |
82 | Frequent falls (HP:0002359) | 2.14957178 |
83 | Lower limb amyotrophy (HP:0007210) | 2.13992950 |
84 | Hyperkalemia (HP:0002153) | 2.13290381 |
85 | Cerebral edema (HP:0002181) | 2.05935125 |
86 | Abnormality of the calcaneus (HP:0008364) | 2.05510891 |
87 | Spinal rigidity (HP:0003306) | 2.05159539 |
88 | Proximal amyotrophy (HP:0007126) | 2.05136788 |
89 | Absent phalangeal crease (HP:0006109) | 2.03883622 |
90 | Increased CSF lactate (HP:0002490) | 2.02909617 |
91 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.01394614 |
92 | Waddling gait (HP:0002515) | 2.01165971 |
93 | Hypoglycemic coma (HP:0001325) | 2.01152948 |
94 | Progressive muscle weakness (HP:0003323) | 2.00356549 |
95 | Deformed tarsal bones (HP:0008119) | 1.97940038 |
96 | Limb-girdle muscle weakness (HP:0003325) | 1.96926489 |
97 | Dicarboxylic aciduria (HP:0003215) | 1.96706976 |
98 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.96706976 |
99 | Scapular winging (HP:0003691) | 1.96422013 |
100 | Abnormality of the foot musculature (HP:0001436) | 1.94514337 |
101 | Fatigable weakness (HP:0003473) | 1.94040591 |
102 | Abnormality of the neuromuscular junction (HP:0003398) | 1.94040591 |
103 | Increased intramyocellular lipid droplets (HP:0012240) | 1.93518015 |
104 | Malignant hyperthermia (HP:0002047) | 1.93394785 |
105 | Foot dorsiflexor weakness (HP:0009027) | 1.93248882 |
106 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.91334855 |
107 | Abnormality of the ischium (HP:0003174) | 1.90841634 |
108 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.88908048 |
109 | Abnormality of alanine metabolism (HP:0010916) | 1.88908048 |
110 | Hyperalaninemia (HP:0003348) | 1.88908048 |
111 | Bulbar palsy (HP:0001283) | 1.88524701 |
112 | Conjunctival hamartoma (HP:0100780) | 1.88146216 |
113 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.87258007 |
114 | Lactic acidosis (HP:0003128) | 1.86585498 |
115 | Popliteal pterygium (HP:0009756) | 1.71074129 |
116 | Type 2 muscle fiber atrophy (HP:0003554) | 1.59927891 |
117 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.58432445 |
118 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.58432445 |
119 | Long clavicles (HP:0000890) | 1.57077492 |
120 | Nonprogressive disorder (HP:0003680) | 1.56271567 |
121 | Shoulder girdle muscle weakness (HP:0003547) | 1.54591814 |
122 | Paralysis (HP:0003470) | 1.51400730 |
123 | Steppage gait (HP:0003376) | 1.51052316 |
124 | Pelvic girdle muscle weakness (HP:0003749) | 1.50178155 |
125 | Muscle fiber atrophy (HP:0100295) | 1.47938302 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TTN | 7.05402680 |
2 | OBSCN | 5.64390914 |
3 | PHKG2 | 4.93391979 |
4 | PHKG1 | 4.93391979 |
5 | PDK4 | 3.24755589 |
6 | PDK3 | 3.24755589 |
7 | LMTK2 | 2.79827993 |
8 | DMPK | 2.69660489 |
9 | BCKDK | 2.63149265 |
10 | MYLK | 2.54946473 |
11 | TRIB3 | 2.53950919 |
12 | MUSK | 2.48743423 |
13 | PINK1 | 2.46221289 |
14 | NEK1 | 2.45084560 |
15 | PKN2 | 2.19935871 |
16 | PIK3CA | 2.13298852 |
17 | PDK2 | 2.02026744 |
18 | NME1 | 1.86753941 |
19 | MAP2K3 | 1.61890873 |
20 | TIE1 | 1.41596111 |
21 | MAP3K7 | 1.38726336 |
22 | PIK3CG | 1.34757108 |
23 | STK24 | 1.27547248 |
24 | MAPK12 | 1.26428169 |
25 | MARK1 | 1.20635466 |
26 | LIMK1 | 1.12179798 |
27 | GRK7 | 1.07260474 |
28 | MAPKAPK3 | 1.06688331 |
29 | PRKD1 | 1.03512389 |
30 | PAK3 | 1.00020884 |
31 | CAMK2D | 0.99532849 |
32 | PRKAA1 | 0.92961962 |
33 | ILK | 0.88905236 |
34 | MOS | 0.86654721 |
35 | PRKAA2 | 0.85047479 |
36 | MAP3K3 | 0.83471137 |
37 | ZAK | 0.78789375 |
38 | TRPM7 | 0.77447504 |
39 | MAP3K5 | 0.75368783 |
40 | ROCK1 | 0.75120955 |
41 | CCNB1 | 0.73727113 |
42 | RIPK1 | 0.71051233 |
43 | PKN1 | 0.68162119 |
44 | STK38L | 0.65849377 |
45 | MAP3K13 | 0.64163412 |
46 | STK4 | 0.63641688 |
47 | DYRK1B | 0.58603590 |
48 | CDC42BPA | 0.57968400 |
49 | MAP2K4 | 0.56827531 |
50 | PDGFRA | 0.56430152 |
51 | FLT3 | 0.55576538 |
52 | NEK9 | 0.55287363 |
53 | ERBB3 | 0.54971972 |
54 | MAP2K6 | 0.54256459 |
55 | CAMK4 | 0.53099368 |
56 | ICK | 0.51344389 |
57 | AKT2 | 0.51237305 |
58 | EPHB1 | 0.50957336 |
59 | INSRR | 0.49503250 |
60 | CAMK2B | 0.49198176 |
61 | CAMK2G | 0.48797736 |
62 | WNK4 | 0.47621686 |
63 | STK38 | 0.47432839 |
64 | PRKACB | 0.47036611 |
65 | NME2 | 0.46542099 |
66 | ROCK2 | 0.45692630 |
67 | KSR2 | 0.45382064 |
68 | DAPK3 | 0.43947305 |
69 | CAMK2A | 0.42495102 |
70 | RPS6KC1 | 0.42008680 |
71 | RPS6KL1 | 0.42008680 |
72 | TGFBR2 | 0.41312738 |
73 | KDR | 0.38518853 |
74 | MAP3K11 | 0.38509227 |
75 | TAOK1 | 0.34808028 |
76 | RPS6KA6 | 0.34640754 |
77 | PRKACA | 0.34315756 |
78 | WNK1 | 0.32399426 |
79 | MAPK11 | 0.30896182 |
80 | PDPK1 | 0.30523862 |
81 | PRKACG | 0.28858606 |
82 | LATS2 | 0.28341544 |
83 | SGK2 | 0.27956489 |
84 | SIK1 | 0.26927462 |
85 | CAMK1 | 0.25668894 |
86 | RPS6KA1 | 0.25540056 |
87 | PTK6 | 0.25438475 |
88 | PTK2B | 0.24238457 |
89 | TBK1 | 0.23680287 |
90 | PDK1 | 0.22829084 |
91 | MAPK10 | 0.21123367 |
92 | MTOR | 0.20855309 |
93 | SGK1 | 0.20629108 |
94 | ARAF | 0.20427053 |
95 | RPS6KB1 | 0.19883079 |
96 | PRKG1 | 0.19116565 |
97 | EPHA3 | 0.18904775 |
98 | RPS6KA3 | 0.18536878 |
99 | MARK2 | 0.18238717 |
100 | TAOK2 | 0.18034241 |
101 | PRKD3 | 0.16833278 |
102 | MAPK7 | 0.16538627 |
103 | PRKCE | 0.15815001 |
104 | PRKCH | 0.14945613 |
105 | RPS6KB2 | 0.14799587 |
106 | DAPK2 | 0.14230659 |
107 | MARK3 | 0.13640800 |
108 | MAP3K1 | 0.13034689 |
109 | ZAP70 | 0.12949292 |
110 | LATS1 | 0.12312198 |
111 | MAPK13 | 0.11507069 |
112 | SGK494 | 0.10677329 |
113 | SGK223 | 0.10677329 |
114 | LRRK2 | 0.10157473 |
115 | STK11 | 0.10138627 |
116 | MAP3K6 | 0.09970233 |
117 | SGK3 | 0.09624657 |
118 | FER | 0.09274804 |
119 | MAPK4 | 0.08979684 |
120 | RPS6KA2 | 0.08883625 |
121 | MAP2K1 | 0.08786808 |
122 | PRPF4B | 0.08617611 |
123 | RAF1 | 0.07747702 |
124 | MAP3K10 | 0.07223319 |
125 | NLK | 0.06960430 |
126 | EPHB2 | 0.06857919 |
127 | PAK6 | 0.06343961 |
128 | CDK19 | 0.06074758 |
129 | EEF2K | 0.05883292 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.75691652 |
2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.32081284 |
3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.28896435 |
4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.81341421 |
5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.69933996 |
6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.26974918 |
7 | Parkinsons disease_Homo sapiens_hsa05012 | 3.24367952 |
8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.23421189 |
9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.14536902 |
10 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.73189847 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.65754258 |
12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.55674702 |
13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.45147887 |
14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.29156818 |
15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.24978331 |
16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01700537 |
17 | Huntingtons disease_Homo sapiens_hsa05016 | 1.99179778 |
18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.80690162 |
19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.73446590 |
20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64206646 |
21 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.48826920 |
22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.47092951 |
23 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42129285 |
24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30882797 |
25 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.26774002 |
26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.24323416 |
27 | Insulin resistance_Homo sapiens_hsa04931 | 1.24057982 |
28 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.17459779 |
29 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.14731118 |
30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04992996 |
31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.01670471 |
32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.96840287 |
33 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94012246 |
34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90443839 |
35 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.89837694 |
36 | Galactose metabolism_Homo sapiens_hsa00052 | 0.89047725 |
37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.87647435 |
38 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.86824682 |
39 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.83788498 |
40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.79078174 |
41 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.78022326 |
42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.77400089 |
43 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72307783 |
44 | Circadian rhythm_Homo sapiens_hsa04710 | 0.69928800 |
45 | Focal adhesion_Homo sapiens_hsa04510 | 0.69412695 |
46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69096649 |
47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66215093 |
48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.66034314 |
49 | Tight junction_Homo sapiens_hsa04530 | 0.65399813 |
50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.64735189 |
51 | Long-term potentiation_Homo sapiens_hsa04720 | 0.63378458 |
52 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61225127 |
53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61050689 |
54 | Lysine degradation_Homo sapiens_hsa00310 | 0.59460150 |
55 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58221520 |
56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54572030 |
57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.52375871 |
58 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51879116 |
59 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48794702 |
60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47960869 |
61 | Peroxisome_Homo sapiens_hsa04146 | 0.46405881 |
62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45425603 |
63 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.42393061 |
64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39580339 |
65 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.38199683 |
66 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38010365 |
67 | Salivary secretion_Homo sapiens_hsa04970 | 0.36013545 |
68 | Renin secretion_Homo sapiens_hsa04924 | 0.34054805 |
69 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33110058 |
70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32018911 |
71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30693529 |
72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29081152 |
73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28824858 |
74 | Adherens junction_Homo sapiens_hsa04520 | 0.28441812 |
75 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.25957852 |
76 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.25845247 |
77 | Insulin secretion_Homo sapiens_hsa04911 | 0.25645969 |
78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25591261 |
79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.25480494 |
80 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.25188820 |
81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.23911509 |
82 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.23889314 |
83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22829750 |
84 | Amoebiasis_Homo sapiens_hsa05146 | 0.21534190 |
85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.20803831 |
86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.19685436 |
87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.19427597 |
88 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.19154722 |
89 | Histidine metabolism_Homo sapiens_hsa00340 | 0.18397038 |
90 | Sulfur relay system_Homo sapiens_hsa04122 | 0.18040703 |
91 | Long-term depression_Homo sapiens_hsa04730 | 0.15652222 |
92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.15249894 |
93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.14779243 |
94 | Melanogenesis_Homo sapiens_hsa04916 | 0.14343792 |
95 | Purine metabolism_Homo sapiens_hsa00230 | 0.13621137 |
96 | Platelet activation_Homo sapiens_hsa04611 | 0.13372494 |
97 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.11681001 |
98 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.11038369 |
99 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.10902003 |
100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.10475974 |
101 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.08785451 |
102 | Olfactory transduction_Homo sapiens_hsa04740 | 0.08376043 |
103 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.07662666 |
104 | Gap junction_Homo sapiens_hsa04540 | 0.04199455 |
105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.04130367 |
106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.02816899 |
107 | Circadian entrainment_Homo sapiens_hsa04713 | 0.02272335 |
108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.02180739 |
109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.00058406 |
110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.00033236 |
111 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0810264 |
112 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0655254 |
113 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.0561814 |
114 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.0415605 |
115 | Bile secretion_Homo sapiens_hsa04976 | -0.0342804 |
116 | Cholinergic synapse_Homo sapiens_hsa04725 | -0.0205504 |
117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0134570 |
118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0070871 |